Johnson & Johnson (JNJ) vs Exxon Mobil Corporation (XOM)

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.

Exxon Mobil Corporation is an integrated oil and gas company engaged in the global exploration, production, and refining of petroleum. In 2025, the company produced 3.3 million barrels of liquids per day and 8.4 billion cubic feet of natural gas daily. As of the end of 2025, ExxonMobil reported 19.3 billion barrels of oil equivalent in reserves, with liquids accounting for 69% of the total. The company is also among the world’s largest refiners, with total global refining capacity of 4.1 million barrels of oil per day, and ranks as a leading producer of both commodity and specialty chemicals.